These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 9198888

  • 1. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M, Schlaepfer J, Kappenberger L, Fromer M.
    Schweiz Med Wochenschr; 1997 Apr 12; 127(15):623-30. PubMed ID: 9198888
    [Abstract] [Full Text] [Related]

  • 2. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ, Fananapazir L.
    Circulation; 1992 Jan 12; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep 12; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

  • 4. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ, Greiss I, Talakic M, Guerra PG, Macle L, Thibault B, Dubuc M, Roy D.
    Can J Cardiol; 2005 Apr 12; 21(5):441-8. PubMed ID: 15861263
    [Abstract] [Full Text] [Related]

  • 5. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar 12; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 6. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF, Keeling PJ, Slade AK, McKenna WJ.
    Arch Mal Coeur Vaiss; 1992 Dec 12; 85 Spec No 4():31-6. PubMed ID: 1307192
    [Abstract] [Full Text] [Related]

  • 7. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
    Göktekin O, Ritsushi K, Matsumoto K, Hiroshi M.
    Anadolu Kardiyol Derg; 2002 Sep 12; 2(3):226-30. PubMed ID: 12223331
    [Abstract] [Full Text] [Related]

  • 8. [Sudden death during Holter electrocardiographic monitoring in a patient with hypertrophic cardiomyopathy].
    Sato M, Takenaka K, Yamashita T, Koike S, Natori K, Nakahara K.
    J Cardiol; 1998 May 12; 31(5):297-303. PubMed ID: 9617660
    [Abstract] [Full Text] [Related]

  • 9. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I.
    Fundam Clin Pharmacol; 2010 Oct 12; 24(5):637-52. PubMed ID: 20727015
    [Abstract] [Full Text] [Related]

  • 10. [Cardiomyopathies. VIII. Sudden death in hypertrophic cardiomyopathy].
    Alfonso F.
    Rev Esp Cardiol; 1996 Apr 12; 49(4):288-304. PubMed ID: 8650406
    [Abstract] [Full Text] [Related]

  • 11. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M, Mohammadzadeh S, Taherpour M, Faghfurian B, Fazelifar AF, Alizadeh A, Rad MA, Sadr-Ameli MA.
    Europace; 2009 May 12; 11(5):643-9. PubMed ID: 19164362
    [Abstract] [Full Text] [Related]

  • 12. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
    Kowey PR, Eisenberg R, Engel TR.
    N Engl J Med; 1984 Jun 14; 310(24):1566-9. PubMed ID: 6539421
    [Abstract] [Full Text] [Related]

  • 13. [Sudden death and obstructive hypertrophic cardiomyopathy].
    Baille N.
    Ann Cardiol Angeiol (Paris); 1985 Mar 14; 34(3):155-60. PubMed ID: 3890678
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N, de Chillou C, Aliot E, McKenna WJ.
    Arch Mal Coeur Vaiss; 1999 Apr 14; 92 Spec No 1():65-73. PubMed ID: 10326160
    [Abstract] [Full Text] [Related]

  • 15. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH, Schümmelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S.
    Herz; 2005 Mar 14; 30(2):102-10. PubMed ID: 15875098
    [Abstract] [Full Text] [Related]

  • 16. Ambulatory monitoring of the sudden death of an adolescent with hypertrophic cardiomyopathy.
    Gardin LL, Nanton MA, Hanna BD.
    Can J Cardiol; 1994 Jun 14; 10(5):548-50. PubMed ID: 8012885
    [Abstract] [Full Text] [Related]

  • 17. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y, Cui YH, Wang DW.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):401-4. PubMed ID: 15061995
    [Abstract] [Full Text] [Related]

  • 18. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 19. Role of invasive and noninvasive testing in risk stratification of sudden cardiac death in children and young adults: an electrophysiologic perspective.
    Attari M, Dhala A.
    Pediatr Clin North Am; 2004 Oct 01; 51(5):1355-78. PubMed ID: 15331288
    [Abstract] [Full Text] [Related]

  • 20. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ.
    J Insur Med; 2002 Oct 01; 34(1):43-60. PubMed ID: 15303593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.